Peter Forsell
Tracked across 2 events · 38 articles · First seen Aug 14, 2026 · Last active Sep 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Implantica AG, a Liechtenstein-based medtech company, received Premarket Approval (PMA) from the U.S. United States — Food and Drug Administration (FDA) for its RefluxStop device, an implantable treatment for gastroesophageal reflux disease (GERD). The approval,…
Impact: Peter Forsell, CEO and founder, is the key executive driving the company's strategy and public communications around the FDA approval and U.S. launch.
Aug 20, 2026 · 32 articles
Business
Impact: Peter Forsell, CEO of Implantica, is scheduled to speak at the Q2 2026 presentation, representing the company's leadership and discussing results.
Aug 14, 2026 · 6 articles
Implantica
ceo and founder
↔
Peter Forsell
Peter Forsell is the founder and current CEO of Implantica, a medical technology
ERGEN INTELLIGENCE
Track Peter Forsell live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard